InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
6
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Bodenstedt Matthias, Chief Financial Officer. Officer active across 1 company, notably MoonLake Immunotherapeutics. Cumulatively, 9 disclosures have been recorded. Split: 0 buy · 6 sells. Total volume traded: €5.6m. Activity tracked since 19 December 2023. The latest transaction was filed on 11 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations9 total
39,120 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-071075:0
15,082 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-070259:0
2,794 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-070259:1
13,653 shares@ US$20.020.025% mcap50.0% of flowClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-055799:0
13,653 shares@ US$20.020.025% mcap50.0% of flowClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-26-055799
95,763 shares0Class A ordinary shares, par value $0.0001 per shareSEC:0001213900-25-019672:0
94,736 shares@ US$59.2291.7% of flowClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-23-097671:0
62,972 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001013762-23-001300:0
410,796 sharesClass A ordinary shares, par value $0.0001 per shareSEC:0001213900-23-028294:0
9 of 9 declarations
About Bodenstedt Matthias
Matthias Bodenstedt serves as the Chief Financial Officer at MoonLake Immunotherapeutics. In this role, he oversees the company's financial operations, including budgeting and financial reporting. His expertise in finance and management enables him to contribute to the financial strategy and growth of MoonLake. He plays a vital role in managing the company's financial resources.
